FINT KOREA is a materials and medical device company that designs and manufactures its own biodegradable composite materials, then develops and produces microneedles and implantable medical devices from them.
Laser processing of a biodegradable stent
From material design to forming and manufacturing, we do it all in-house. Every product is built on these three technologies.
TECH 01Material technology that controls degradation rate and physical properties for each application through biocompatible polymer design and compounding and milling processes.
TECH 02Dissolving microneedle design and molding technology that delivers drugs and active ingredients precisely into the skin without pain.
TECH 03Design and manufacturing technology for implantable medical devices, including biodegradable stent tubing and absorbable hemostatic materials.
A patch that delivers active ingredients painlessly through dissolving microneedles, available in medical and cosmetic lines.
A hemostatic material that effectively controls bleeding during surgery and is gradually degraded and absorbed in the body, so no removal is needed.
Medical and industrial compounds, plus specimen fabrication and physical property analysis services.
Medical devices such as biodegradable coronary and peripheral vascular stents that safely degrade once their job in the body is done.
We operate a corporate R&D center (Jeonnam Nano Bio Research Center) and a cleanroom production facility (KIMIRo support center) side by side, carrying out material synthesis and analysis, prototyping, performance evaluation and pilot production in one continuous flow.
Certifications and designations that verify our quality, technology and management capabilities, along with registered patents covering our core materials and processes. For awards and commendations, see Certifications.
10월 30일부터 11월 1일까지 김대중컨벤션센터에서 열리는 ‘2025 광주 메디뷰티산업전’에서 용해성 스킨케어 패치 FineCare 제품군을 전시한다. 연어…
Learn more
2025 G-유니콘 육성 프로그램 경진대회에서 파인트코리아 등 5개사 선정. 파인트코리아는 ‘수요 맞춤형 의료용 생분해성 복합소재’를 개발하며, 사업…
Learn more
전남 장성 나노바이오연구센터 내 바이오 클린룸(GMP) 시설투자 등 총 50억 원 규모의 투자협약을 체결했다. 장성 첨단3지구 조성 후 부지 매입과 자…
Learn moreBusiness partnerships, product purchases, research collaboration — whatever it is, feel free to reach out.
Propose a B2B collaboration: OEM/ODM, material supply, joint research and more.
Leave a general question about our products or technology and our team will get back to you.
Find our headquarters, factory and R&D center, plus visitor information.